|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
La Jolla Pharmaceutical Co (LJPC) |
|
|
$6.22 0.00 (0.00%) as of 4:30 Thu 8/18
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
27,470,000 |
| Market
Cap: |
170.86(M) |
| Last
Volume: |
2,592,323 |
Avg
Vol: |
2,585,089 |
| 52
Week Range: |
$6.22 - $6.22 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-04-30 |
4 |
A |
$6.84 |
$1,594 |
D/D |
233 |
494 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-04-30 |
4 |
A |
$6.84 |
$793 |
D/D |
116 |
78,107 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-04-15 |
4 |
A |
$6.09 |
$798 |
D/D |
131 |
77,991 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-04-15 |
4 |
A |
$6.09 |
$572 |
D/D |
94 |
5,530 |
|
- |
|
| Wellinghoff Darryl |
Chief Commercial Officer |
• – – |
2019-04-15 |
4 |
A |
$6.09 |
$1,589 |
D/D |
261 |
261 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2019-04-15 |
4 |
A |
$6.09 |
$12 |
D/D |
2 |
1,263,895 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-04-15 |
4 |
A |
$6.09 |
$1,589 |
D/D |
261 |
1,534 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-03-29 |
4 |
A |
$5.47 |
$323 |
D/D |
59 |
1,273 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2019-03-29 |
4 |
A |
$5.47 |
$514 |
D/D |
94 |
1,263,893 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-03-29 |
4 |
A |
$5.47 |
$191 |
D/D |
35 |
5,436 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-03-29 |
4 |
A |
$5.47 |
$799 |
D/D |
146 |
77,860 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-03-15 |
4 |
A |
$6.49 |
$318 |
D/D |
49 |
1,214 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-03-15 |
4 |
A |
$6.49 |
$188 |
D/D |
29 |
5,401 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2019-03-15 |
4 |
A |
$6.49 |
$1,266 |
D/D |
195 |
1,263,799 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-03-15 |
4 |
A |
$6.49 |
$792 |
D/D |
122 |
77,714 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2019-02-28 |
4 |
A |
$4.85 |
$1,266 |
D/D |
261 |
1,263,604 |
|
- |
|
| Carver Jennifer |
Chief Operating Officer |
• – – |
2019-02-28 |
4 |
A |
$4.85 |
$1,116 |
D/D |
230 |
14,049 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-02-28 |
4 |
A |
$4.85 |
$315 |
D/D |
65 |
1,165 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-02-28 |
4 |
A |
$4.85 |
$795 |
D/D |
164 |
77,592 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-02-28 |
4 |
A |
$4.85 |
$194 |
D/D |
40 |
5,372 |
|
- |
|
| Carver Jennifer |
Chief Operating Officer |
• – – |
2019-02-15 |
4 |
A |
$5.30 |
$1,219 |
D/D |
230 |
13,819 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2019-02-15 |
4 |
A |
$5.30 |
$318 |
D/D |
60 |
1,100 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2019-02-15 |
4 |
A |
$5.30 |
$1,267 |
D/D |
239 |
1,263,343 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2019-02-15 |
4 |
A |
$5.30 |
$191 |
D/D |
36 |
5,332 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2019-02-15 |
4 |
A |
$5.30 |
$800 |
D/D |
151 |
77,428 |
|
- |
|
333 Records found
|
|
Page 9 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
